ClinicalTrials.gov
ClinicalTrials.gov Menu

Efficacy and Safety of IPI-504 With Trastuzumab Pretreated, Locally Advanced or Metastatic HER2 Positive Breast Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00817362
Recruitment Status : Terminated (Limited efficacy response observed during interim analysis.)
First Posted : January 6, 2009
Last Update Posted : December 11, 2012
Sponsor:
Information provided by (Responsible Party):
Infinity Pharmaceuticals, Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : August 2010
  Actual Study Completion Date : May 2011
  Certification/Extension First Submitted : December 6, 2012